TwinBeech Capital’s Core Laboratories CLB Stock Holding History

TwinBeech Capital’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8,003	Closed	-$312K	–	603
2021 Q2	$312K	Buy	+8,003	New	+$287K	0.04%	367
2020 Q3	–	Sell	-23,341	Closed	-$474K	–	450
2020 Q2	$474K	Buy	+23,341	New	+$418K	0.1%	240
2020 Q1	–	Sell	-8,049	Closed	-$303K	–	315
2019 Q4	$303K	Buy	+8,049	New	+$362K	0.09%	293

Other funds holding CLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

TwinBeech Capital's CLB Position: Q3 2021 in Review

TwinBeech Capital sold out of Core Laboratories (CLB) in Q3 2021, closing a stake of 8,003 shares — an estimated $312K sold.

TwinBeech Capital first reported a position in CLB in Q4 2019 and held it in 3 quarters. The position peaked at $474K in Q2 2020. 198 funds tracked by Wall St. Rank hold CLB as of Q3 2021.

TwinBeech Capital reported no remaining Core Laboratories position as of Q3 2021 after selling out during the quarter.
TwinBeech Capital sold 8,003 Core Laboratories shares in Q3 2021, an estimated $312K.
TwinBeech Capital first reported a position in Core Laboratories in Q4 2019 and held it in 3 quarters.
TwinBeech Capital's Core Laboratories position peaked at $474K in Q2 2020.
198 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2021.

Based on TwinBeech Capital's 13F filing for Q3 2021, filed 15 Nov 2021.